Results 101 to 110 of about 15,288 (159)

Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy. [PDF]

EMBO Mol Med
Baurès M, Vieira Aleixo AS, Pacreau E, Koshy A, Friedrich V, Diedisheim M, Raigel M, Hua Y, Dariane C, Boutillon F, Kenner L, Marine JC, Laverny G, Metzger D, Rambow F, Guidotti JE, Goffin V.   +16 more
europepmc   +1 more source

Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia. [PDF]

BMC Urol
Bazarbashi S, Abdelmotal AS, Arabi T, Fallatah W, Alzannan N, Elhassan T, Aseafan M, Mahroos M, Aljishi M, Busbaih A, Aldandan R, Rauf MS, Almugbel FA, Azam F, Almansour M.   +14 more
europepmc   +1 more source

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer. [PDF]

Proc Natl Acad Sci U S A
Traphagen NA, Wheeler E, Li R, Akhshi T, Ravindranathan R, Alfieri C, Lu F, Ahmed B, Tewari AK, Balk SP, Nelson PS, Corey E, Long H, D'Andrea AD, Qiu X, Brown M.   +15 more
europepmc   +1 more source

PARP Inhibitors in the Treatment of Prostate Cancer: An Analysis of the Clinical Trial Landscape. [PDF]

Cancer Med
Chen Y, Cao J, Huang R, Lou J, Gu J, Luo Z, Yao T, Xie J.   +7 more
europepmc   +1 more source

Severe exfoliative dermatitis induced by apalutamide in a mHSPC patient: A case report. [PDF]

Medicine (Baltimore)
Chen H, Li T, Fan J, Liu J.
europepmc   +1 more source

Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research. [PDF]

Cureus
Higgi A, Melvin C, Abdelrasheed A, Wilson K.   +3 more
europepmc   +1 more source

Targeting the Androgen Receptor Pathway in Prostate Cancer: A PROTrACted Struggle. [PDF]

Clin Cancer Res
Nyquist MD, Nelson PS.
europepmc   +1 more source

Immunotherapeutic Strategies for Prostate Cancer: A Comprehensive Review. [PDF]

Cancers (Basel)
Flores-Islas AK, Rico-Fuentes C, Sierra-Díaz E, García-Chagollán M, Pereira-Suárez AL, Zepeda-Nuño JS, Moreno-Ortiz JM, Ramírez-de-Arellano A.   +7 more
europepmc   +1 more source

Proteoglycans in Prostate Cancer Progression and Therapy Resistance. [PDF]

Medicina (Kaunas)
Samaržija I.
europepmc   +1 more source

In vitro cytotoxicity of medicinal plants used in prostate cancer management in Africa: a systematic review. [PDF]

Trop Med Health
Bwesigye T, Nerima B, Kyambadde J, Mulindwa J, Byarugaba I, Sekandi P.   +5 more
europepmc   +1 more source